Results 221 to 230 of about 1,404,058 (313)
Five-year survival of patients with non-small cell lung cancer treated with alkalization therapy. [PDF]
Kachi S +5 more
europepmc +1 more source
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
A. Shaw +17 more
semanticscholar +1 more source
Bio‐based and (semi‐)synthetic zwitterion‐modified novel materials and fully synthetic next‐generation alternatives show the importance of material design for different biomedical applications. The zwitterionic character affects the physiochemical behavior of the material and deepens the understanding of chemical interaction mechanisms within the ...
Theresa M. Lutz +3 more
wiley +1 more source
Pembrolizumab-Induced Chronic Rhinosinusitis in a Patient With Non-Small Cell Lung Cancer. [PDF]
Yamasaki Y +5 more
europepmc +1 more source
Tracking the Evolution of Non‐Small‐Cell Lung Cancer
M. Jamal-Hanjani +82 more
semanticscholar +1 more source
A programmable interpenetrating double‐network architecture, created via 3D‐TIPS printing and resin infusion, synergistically combines thermoplastic and thermosetting elastomers to balance structural rigidity and surface softness—crucial for paediatric laryngeal stents.
Elizabeth F. Maughan +14 more
wiley +1 more source
A Retrospective Study of First-Line Immunotherapy for Advanced Non-Small Cell Lung Cancer in the Elderly. [PDF]
Yang S, Zhu Y, Liu S, Xiao K.
europepmc +1 more source
We introduce a nucleic acid nanoparticle (NANP) platform designed to be rrecognized by the human innate immune system in a regulated manner. By changing chemical composition while maintaining constant architectural parameters, we identify key determinants of immunorecognition enabling the rational design of NANPs with tunable immune activation profiles
Martin Panigaj +21 more
wiley +1 more source
Emerging Targets in Non-Small Cell Lung Cancer. [PDF]
Wang J, Biglow L, Baumgart M.
europepmc +1 more source

